BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31495785)

  • 1. Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells.
    Xiao L; Zhou Z; Li W; Peng J; Sun Q; Zhu H; Song Y; Hou JL; Sun J; Cao HC; Zhongyi D; Wu D; Liu L
    Aging (Albany NY); 2019 Sep; 11(17):7123-7149. PubMed ID: 31495785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma.
    Zhang CZ; Chen SL; Wang CH; He YF; Yang X; Xie D; Yun JP
    Cancer Res; 2018 Jan; 78(1):51-63. PubMed ID: 29066512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma.
    Tang B; Tian Y; Liao Y; Li Z; Yu S; Su H; Zhong F; Yuan G; Wang Y; Yu H; Tomlinson S; Qiu X; He S
    Cell Death Dis; 2019 Jan; 10(2):52. PubMed ID: 30718464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.
    Tang J; Wang G; Zhang M; Li FY; Sang Y; Wang B; Hu K; Wu Y; Luo R; Liao D; Cao J; Wang X; Wang L; Zhang R; Zhang X; Deng WG; Xie D; Xu RH; Kang T
    Oncotarget; 2014 Nov; 5(21):10778-90. PubMed ID: 25360999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.
    Lin J; Chen L; Wu D; Lin J; Liu B; Guo C
    Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p /519-5p Family and Modulating the Expression of CBX8.
    Liu J; Wang D; Long Z; Liu J; Li W
    Cell Physiol Biochem; 2018; 48(1):173-184. PubMed ID: 30007986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBX8 interacts with chromatin PTEN and is involved in regulating mitotic progression.
    Choi BH; Colon TM; Lee E; Kou Z; Dai W
    Cell Prolif; 2021 Nov; 54(11):e13110. PubMed ID: 34592789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL.
    Chen H; Su Y; Yang L; Xi L; Li X; Lan B; Liu M; Xuan C
    J Cell Physiol; 2023 Nov; 238(11):2710-2723. PubMed ID: 37733753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBX8 promotes tumorigenesis and confers radioresistance in esophageal squamous cell carcinoma cells through targeting APAF1.
    Zhang Y; Chen H; Zhu H; Sun X
    Gene; 2019 Aug; 711():143949. PubMed ID: 31255735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway.
    Yuan GJ; Chen X; Lu J; Feng ZH; Chen SL; Chen RX; Wei WS; Zhou FJ; Xie D
    Cancer Sci; 2017 Nov; 108(11):2166-2175. PubMed ID: 28837252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between chromobox homolog 8 and key factors of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhu X; Luo W; Bei C; Kong J; Zhang S; Fu Y; Li D; Tan S
    Cancer Cell Int; 2019; 19():340. PubMed ID: 31889893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
    Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
    Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBX8, a novel DNA repair protein, promotes tumorigenesis in human esophageal carcinoma.
    Xiao W; Ou C; Qin J; Xing F; Sun Y; Li Z; Qiu J
    Int J Clin Exp Pathol; 2014; 7(8):4817-26. PubMed ID: 25197352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-Like Growth Factor-1 Modulates Polycomb Cbx8 Expression and Inhibits Colon Cancer Cell Apoptosis.
    Yang S; Liu W; Li M; Wen J; Zhu M; Xu S
    Cell Biochem Biophys; 2015 Apr; 71(3):1503-7. PubMed ID: 25398592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
    Wu SY; Lan SH; Wu SR; Chiu YC; Lin XZ; Su IJ; Tsai TF; Yen CJ; Lu TH; Liang FW; Li CY; Su HJ; Su CL; Liu HS
    Hepatology; 2018 Jul; 68(1):141-154. PubMed ID: 29328502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.